Literature DB >> 12213303

Cytochrome c release and caspase activation after traumatic brain injury.

Patrick G Sullivan1, Jeffrey N Keller, Wendy L Bussen, Stephen W Scheff.   

Abstract

Experimental traumatic brain injury (TBI) results in a rapid and significant necrosis of cortical tissue at the site of injury. In the ensuing hours and days, secondary injury exacerbates the primary damage resulting in significant neurological dysfunction. The identification of cell death pathways that mediate this secondary traumatic injury have not been elucidated, however recent studies have implicated a role for apoptosis in the neuropathology of traumatic brain injury. The present study utilized a controlled cortical impact model of brain injury to assess the involvement of apoptotic pathways: release of cytochrome c from mitochondria and the activation of caspase-1- and caspase-3-like proteases in the injured cortex at 6, 12 and 24 h post-injury. Collectively, these results demonstrate cytochrome c release from mitochondria and its redistribution into the cytosol occurs in a time-dependent manner following TBI. The release of cytochrome c is accompanied by a time-dependent increase in caspase-3-like protease activity with no apparent increase in caspase-1-like activity. However, pretreatment with a general caspase inhibitor had no significant effect on the amount of cortical damage observed at 7 days post-injury. Our data suggest that several pro-apoptotic events occur following TBI, however the translocation of cytochrome c itself and/or other events upstream of caspase activation/inhibition may be sufficient to induce neuronal cell death. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213303     DOI: 10.1016/s0006-8993(02)02968-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  48 in total

Review 1.  Critical appraisal of neuroprotection trials in head injury: what have we learned?

Authors:  Christos M Tolias; M Ross Bullock
Journal:  NeuroRx       Date:  2004-01

2.  Mitochondria-associated microRNAs in rat hippocampus following traumatic brain injury.

Authors:  Wang-Xia Wang; Nishant P Visavadiya; Jignesh D Pandya; Peter T Nelson; Patrick G Sullivan; Joe E Springer
Journal:  Exp Neurol       Date:  2015-01-03       Impact factor: 5.330

3.  Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury.

Authors:  Chun-Shu Piao; David J Loane; Bogdan A Stoica; Shihong Li; Marie Hanscom; Rainier Cabatbat; Klas Blomgren; Alan I Faden
Journal:  Neurobiol Dis       Date:  2012-03-09       Impact factor: 5.996

4.  Neuroproteomic study of nitrated proteins in moderate traumatic brain injured rats treated with gamma glutamyl cysteine ethyl ester administration post injury: Insight into the role of glutathione elevation in nitrosative stress.

Authors:  Moses Henderson; Brittany Rice; Andrea Sebastian; Patrick G Sullivan; Christina King; Renã A S Robinson; Tanea T Reed
Journal:  Proteomics Clin Appl       Date:  2016-11-11       Impact factor: 3.494

Review 5.  Postischemic oxidative stress promotes mitochondrial metabolic failure in neurons and astrocytes.

Authors:  Gary Fiskum; Camelia A Danilov; Zara Mehrabian; Linda L Bambrick; Tibor Kristian; Mary C McKenna; Irene Hopkins; E M Richards; Robert E Rosenthal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 6.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

7.  Recovery of afferent function and synaptic strength in hippocampal CA1 following traumatic brain injury.

Authors:  Christopher M Norris; Stephen W Scheff
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

8.  Causal role of apoptosis-inducing factor for neuronal cell death following traumatic brain injury.

Authors:  Jennifer E Slemmer; Changlian Zhu; Stefan Landshamer; Raimund Trabold; Julia Grohm; Ardavan Ardeshiri; Ernst Wagner; Marva I Sweeney; Klas Blomgren; Carsten Culmsee; John T Weber; Nikolaus Plesnila
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

9.  Dosing and safety of cyclosporine in patients with severe brain injury.

Authors:  Jimmi Hatton; Bonnie Rosbolt; Philip Empey; Richard Kryscio; Byron Young
Journal:  J Neurosurg       Date:  2008-10       Impact factor: 5.115

10.  Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial.

Authors:  Anna Teresa Mazzeo; Gretchen M Brophy; Charlotte B Gilman; Oscar Luís Alves; Jaime R Robles; Ronald L Hayes; John T Povlishock; M Ross Bullock
Journal:  J Neurotrauma       Date:  2009-12       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.